Similar articles

• Pharmacological activation of IKr impairs conduction in guinea pig hearts.

  Larsen AP, Olesen SP, Grunnet M, Poelzing S. Larsen AP, et al. J Cardiovasc Electrophysiol. 2010 Aug 1;21(8):923-9. doi: 10.1111/j.1540-8167.2010.01733.x. Epub 2010 Feb 16. J Cardiovasc Electrophysiol. 2010. PMID: 20163495
• In vivo effects of the IKr agonist NS3623 on cardiac electrophysiology of the guinea pig.

  Hansen RS, Olesen SP, Rønn LC, Grunnet M. Hansen RS, et al. J Cardiovasc Pharmacol. 2008 Jul;52(1):35-41. doi: 10.1097/FJC.0b013e31817dd013. J Cardiovasc Pharmacol. 2008. PMID: 18594476
• [HERG K+ channel, the target of anti-arrhythmias drugs].

  Guan FY, Yang SJ. Guan FY, et al. Yao Xue Xue Bao. 2007 Jul;42(7):687-91. Yao Xue Xue Bao. 2007. PMID: 17882949 Review. Chinese.
• Electrophysiologic changes in heart failure: focus on pacemaker channels.

  Sartiani L, Stillitano F, Cerbai E, Mugelli A. Sartiani L, et al. Can J Physiol Pharmacol. 2009 Feb;87(2):84-90. doi: 10.1139/Y08-109. Can J Physiol Pharmacol. 2009. PMID: 19234571 Review.
• Cardiac electrophysiological effects of nitric oxide.

  Tamargo J, Caballero R, Gómez R, Delpón E. Tamargo J, et al. Cardiovasc Res. 2010 Sep 1;87(4):593-600. doi: 10.1093/cvr/cvq214. Epub 2010 Jun 28. Cardiovasc Res. 2010. PMID: 20587506 Review.